These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 29795359)
21. New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development. Ycas PD; Zahid H; Chan A; Olson NM; Johnson JA; Talluri SK; Schonbrunn E; Pomerantz WCK Org Biomol Chem; 2020 Jul; 18(27):5174-5182. PubMed ID: 32588860 [TBL] [Abstract][Full Text] [Related]
22. Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay. Ji JZ; Lao KJ; Hu J; Pang T; Jiang ZZ; Yuan HL; Miao JS; Chen X; Ning SS; Xiang H; Guo YM; Yan M; Zhang LY Acta Pharmacol Sin; 2014 Aug; 35(8):1082-92. PubMed ID: 25047514 [TBL] [Abstract][Full Text] [Related]
23. Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening. Zhang D; Han J; Lu W; Lian F; Wang J; Lu T; Tao H; Xiao S; Zhang F; Liu YC; Liu R; Zhang N; Jiang H; Chen K; Zhao C; Luo C Bioorg Chem; 2019 May; 86():494-500. PubMed ID: 30780018 [TBL] [Abstract][Full Text] [Related]
24. Discovery of a novel 53BP1 inhibitor through AlphaScreen-based high-throughput screening. Sun Y; Lu H; Fang X; Xiao S; Yang F; Chen Y; Wang H; Li X; Lu J; Lin H; Luo C; Zhao K; Chen S Bioorg Med Chem; 2021 Mar; 34():116054. PubMed ID: 33571875 [TBL] [Abstract][Full Text] [Related]
25. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation. Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482 [TBL] [Abstract][Full Text] [Related]
26. A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification. Bamborough P; Chung CW; Demont EH; Bridges AM; Craggs PD; Dixon DP; Francis P; Furze RC; Grandi P; Jones EJ; Karamshi B; Locke K; Lucas SCC; Michon AM; Mitchell DJ; Pogány P; Prinjha RK; Rau C; Roa AM; Roberts AD; Sheppard RJ; Watson RJ J Med Chem; 2019 Aug; 62(16):7506-7525. PubMed ID: 31398032 [TBL] [Abstract][Full Text] [Related]
30. Identification of novel bromodomain inhibitors of Tavernelli LE; Alonso VL; Peña I; Rodríguez Araya E; Manarin R; Cantizani J; Martin J; Salamanca J; Bamborough P; Calderón F; Gabarro R; Serra E Antimicrob Agents Chemother; 2024 Aug; 68(8):e0024324. PubMed ID: 39028190 [TBL] [Abstract][Full Text] [Related]
31. Cell-based protein stabilization assays for the detection of interactions between small-molecule inhibitors and BRD4. Schulze J; Moosmayer D; Weiske J; Fernández-Montalván A; Herbst C; Jung M; Haendler B; Bader B J Biomol Screen; 2015 Feb; 20(2):180-9. PubMed ID: 25266565 [TBL] [Abstract][Full Text] [Related]
32. Fragment-based in silico screening of bromodomain ligands. Spiliotopoulos D; Caflisch A Drug Discov Today Technol; 2016 Mar; 19():81-90. PubMed ID: 27769362 [TBL] [Abstract][Full Text] [Related]
33. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors. Raj U; Kumar H; Varadwaj PK J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802 [TBL] [Abstract][Full Text] [Related]
34. The bromodomain-containing protein Ibd1 links multiple chromatin-related protein complexes to highly expressed genes in Tetrahymena thermophila. Saettone A; Garg J; Lambert JP; Nabeel-Shah S; Ponce M; Burtch A; Thuppu Mudalige C; Gingras AC; Pearlman RE; Fillingham J Epigenetics Chromatin; 2018 Mar; 11(1):10. PubMed ID: 29523178 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance. Crawford TD; Vartanian S; Côté A; Bellon S; Duplessis M; Flynn EM; Hewitt M; Huang HR; Kiefer JR; Murray J; Nasveschuk CG; Pardo E; Romero FA; Sandy P; Tang Y; Taylor AM; Tsui V; Wang J; Wang S; Zawadzke L; Albrecht BK; Magnuson SR; Cochran AG; Stokoe D Bioorg Med Chem Lett; 2017 Aug; 27(15):3534-3541. PubMed ID: 28606761 [TBL] [Abstract][Full Text] [Related]
36. Identification of sumoylation inhibitors targeting a predicted pocket in Ubc9. Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY J Chem Inf Model; 2014 Oct; 54(10):2784-93. PubMed ID: 25191977 [TBL] [Abstract][Full Text] [Related]
37. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Shen W; Xu C; Huang W; Zhang J; Carlson JE; Tu X; Wu J; Shi Y Biochemistry; 2007 Feb; 46(8):2100-10. PubMed ID: 17274598 [TBL] [Abstract][Full Text] [Related]
38. Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening. Shishodia S; Nuñez R; Strohmier BP; Bursch KL; Goetz CJ; Olp MD; Jensen DR; Fenske TG; Ordonez-Rubiano SC; Blau ME; Roach MK; Peterson FC; Volkman BF; Dykhuizen EC; Smith BC J Med Chem; 2022 Oct; 65(20):13714-13735. PubMed ID: 36227159 [TBL] [Abstract][Full Text] [Related]